Endostain检测试剂盒 定量检测人血清中Endostain 货号:BI-20742 Endostain 是血管生成抑制剂 应用领域: 1)微血管损伤 2)慢性肾病(CKD) 3) 局部贫血 产品优势: - 检测范围宽
- 6个即用型校准品
- 可当日检测,半小时内出结果
- 只需5ul样本
- 严格按照ICH要求,证实可用于人样本检测
- 可靠、重复性好的实验结果:批内<6%,批间<5%
试剂盒特点: 检测方法:夹心ELISA,96孔,HRP/TMB显色 样本类型:血清、血浆(柠檬酸盐抗凝、EDTA抗凝、肝素抗凝)、尿(参照对应的protocol) 样品量:5ul 标准品范围:0-80 nmol/L(0-1600ng/ml) 检测灵敏度:0.02nmol/L(0+3SD) 孵育条件:2h/1h/30min,室温 单位转换:1 ng/ml = 0.05 nmol/l (MW = 20 kDa) 特异性:只与人样本反应与其他种属无交叉反应 参考文献 | Elevated plasma levels of endostatin are associated with chronic kidney disease. J Chen, LL Hamm, et al.Am J Nephrol, Jan 2012; 35(4): 335-340 | Early-onset coronary artery disease after pediatric kidney transplantation: implicatingthe angiogenesi inhibitor, endostatin. CW Iqbal,et al. Am Surg, Jun 2011; 77(6): 731-735 | Immobilized kidney 28-kDa endostatin-related (KES28kDa) fragment promotes endothelial cell survival.MH Bellini, et al. Am J Nephrol, Jan 2010; 31(3): 255-261 | Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Neel R. Sodha, et al.Am J Physiol Heart Circ Physiol, Feb 2009; 296: H428-H434 | A defective angiogenesis in chronic kidney disease.N Futrakul,et al. Jan 2008; 30(2): 215-217 |
|